[ccpw id="5"]

Home.forex news reportKenvue Stock: Analyst Estimates & Ratings

Kenvue Stock: Analyst Estimates & Ratings

-


Valued at a market cap of $33.5 billion, Kenvue Inc. (KVUE) is a consumer health company based in Summit, New Jersey. It focuses on developing, manufacturing, and marketing everyday health, personal care, and wellness products.

This personal care company has lagged behind the broader market over the past 52 weeks. Shares of KVUE have declined 18.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 16.1%. Moreover, on a YTD basis, the stock is up 1.5%, compared to SPX’s 1.9% return.

Narrowing the focus, KVUE has also underperformed the State Street Consumer Staples Select Sector SPDR ETF (XLP), which rose 3.9% over the past 52 weeks and 7.1% on a YTD basis.

www.barchart.com
www.barchart.com

On Nov. 3, shares of Kenvue rose 12.3% after Kimberly-Clark Corporation (KMB) announced an agreement to acquire the company in a cash-and-stock deal valuing Kenvue at approximately $48.7 billion. The companies said the combination is expected to generate total synergies of approximately $2.1 billion, according to their joint press release.

For the current fiscal year, ending in December, analysts expect KVUE’s EPS to decline 9.7% year over year to $1.03. The company’s earnings surprise history is promising. It met or topped the consensus estimates in each of the last four quarters.

Among the 12 analysts covering the stock, the consensus rating is a “Hold,” which is based on two “Strong Buy” and 10 “Hold” ratings.

www.barchart.com
www.barchart.com

The configuration is notably less bullish than three months ago, with an overall “Moderate Buy” rating, consisting of five analysts suggesting a “Strong Buy.”

On Jan. 23, Nik Modi from RBC Capital maintained a “Hold” rating on KVUE, with a price target of $21, indicating a 20% potential upside from the current price levels.

The mean price target of $19 represents an 8.6% premium from KVUE’s current price levels, while the Street-high price target of $23 suggests a 31.4% potential upside from the current levels.

On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Client Challenge

Client Challenge ...

South Korea Industrial Production Rallies 1.7% In December

Industrial output in South Korea was up a seasonally adjusted 1,7 percent on month in December, Statistics Korea said on Friday.That well exceeded...

Bel Fuse Inc. (BELFA): A Bull Case Theory

We came across a bullish thesis on Bel Fuse Inc. on Value & Error’s Substack. In this article, we will summarize the bulls’...

US moves to open Venezuela’s vast crude reserves to Big Oil

Treasury issues ‘general licence’ that will allow US groups to purchase and resell Venezuelan oil Source link

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img